Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets

About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hormone replacement therapy (HRT), but estrogens in cur...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Zuo, Qianying, Chen, Karen L., Arredondo Eve, Alicia, Liu, Yu-Jeh, Kim, Sung Hoon, Katzenellenbogen, Benita S., Katzenellenbogen, John A., Madak-Erdogan, Zeynep
Formáid: Online Alt Téacs
Teanga:English
Foilsithe / Cruthaithe: MDPI 2021
Ábhair:
Article
Rochtain ar líne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

Ar líne

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

Míreanna comhchosúla